检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

OA02.03 The Third Generation EGFR Inhibitor (EGFR-TKI) HS-10296 in Advanced NSCLC Patients with Resistance to First Generation EGFR-TKI

S. Lu,Q. Wang,G. Zhang, X. Dong,C. Yang,Y. Song,G. Chang, Y. Lu, H. Pan,C. Chiu,Z. Wang,J. Feng,J. Zhou,X. Xu,R. Guo, J. Chen,H. Yang,Y. Chen,Z. Yu, H. Shiah,C. Wang, N. Yang, J. Fang,P. Wang, K. Wang,Y. Hu,J. He,J. Shi,S. Chen,Y. Cheng, W. Su, T. Hsia, J. Cui,Y. Sun

JOURNAL OF THORACIC ONCOLOGY（2019）

引用 13|浏览79
暂无评分
关键词
The third generation EGFR inhibitor HS-10296,Non-small cell lung cancer (NSCLC),EGFR T790M mutation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要